fbpx

Tag Archives: Moderna

The cold supply chain can’t reach everywhere – that’s a big problem for equitable COVID-19 vaccination

Getting vaccines to rural and hard-to-reach areas is critical for public health and ethical reasons. Hector Roqueta Rivero/Moment via Getty Images Timothy Ford, University of Massachusetts Lowell and Charles M. Schweik, University of Massachusetts Amherst To mitigate health inequities and promote social justice, coronavirus vaccines need to get to underserved populations and hard-to-reach communities. There are few places in the …

Read More »

Should pregnant women get the COVID-19 vaccine? Will it protect against asymptomatic infections and mutated viruses? An immunologist answers 3 questions

I am a physician, and I just got my first shot of the Pfizer COVID-19 vaccine. William Petri, CC BY-SA William Petri, University of Virginia This week I was vaccinated against COVID-19 with the Pfizer mRNA vaccine, which brought to mind some frequently asked questions about the Pfizer and Moderna vaccines. I am a professor of infectious diseases at the …

Read More »

How the leading coronavirus vaccines work

Eugene Lu/Shutterstock Sarah Pitt, University of Brighton There are now quite a few COVID-19 vaccines in the pipeline, but two seem to be making promising progress: the one designed by the US biotechnology company Moderna, and the one developed by the University of Oxford in collaboration with AstraZeneca. In both cases, the research teams have built on their previous experience …

Read More »

La vacuna contra la covid-19 no debe ser obligatoria

Shutterstock / Ivi Lichi Iñigo De Miguel Beriain, Universidad del País Vasco / Euskal Herriko Unibertsitatea Las vacunas contra la covid-19 ya están llamando a la puerta. En breve, será posible empezar a distribuirlas. A partir de ese momento, será perentorio responder a una pregunta compleja: ¿deberíamos introducirlas a través de políticas de vacunación obligatoria? La propuesta es tentadora. Las …

Read More »

How mRNA vaccines from Pfizer and Moderna work, why they’re a breakthrough and why they need to be kept so cold

Moderna’s new mRNA vaccine is almost 94.5% effective in large-scale trials. JUSTIN TALLIS/AFP via Getty Images Sanjay Mishra, Vanderbilt University As the weather cools, the number of infections of the COVID-19 pandemic are rising sharply. Hamstrung by pandemic fatigue, economic constraints and political discord, public health officials have struggled to control the surging pandemic. But now, a rush of interim …

Read More »